Page 30 - ARNM-3-2

Advances in Radiotherapy
& Nuclear Medicine Lipid-radiotherapy crosstalk in cancer

radiotherapy and concurrent chemo-radiotherapy in head Plasma metabolomic profiles in liver cancer patients following
and neck cancer patients-comparison of serum metabolome stereotactic body radiotherapy. EBioMedicine. 2020;59:102973.
profiles. Metabolites. 2020;10(2):60.
doi: 10.1016/j.ebiom.2020.102973
doi: 10.3390/metabo10020060
18. Wolny-Rokicka E, Tukiendorf A, Wydmański J,
8. Jelonek K, Krzywon A, Papaj K, et al. Dose-dependence of Brzezniakiewicz-Janus K, Zembroń-Łacny A. The effect
radiotherapy-induced changes in serum levels of choline- of radiotherapy on the concentration of plasma lipids
containing phospholipids; The importance of lower doses in elderly prostate cancer patients. Am J Mens Health.
delivered to large volumes of normal tissues. Strahlenther 2019;13(2):1557988319846328.
Onkol. 2021;197(10):926-934.
doi: 10.1177/1557988319846328
doi: 10.1007/s00066-021-01802-4
19. Shaikh S, Channa NA, Talpur FN, Younis M, Tabassum N.
9. LePechoux C, Faivre-Finn C, Ramella S, et al. ESTRO Radiotherapy improves serum fatty acids and lipid profile in
ACROP guidelines for target volume definition in the breast cancer. Lipids Health Dis. 2017;16(1):92.
thoracic radiation treatment of small cell lung cancer. doi: 10.1186/s12944-017-0481-y
Radiother Oncol. 2020;152:89-95.
20. Giskeødegård GF, Madssen TS, Sangermani M, et al.
doi: 10.1016/j.radonc.2020.07.012 Longitudinal changes in circulating metabolites and
10. Tang X, Chen H, Chen G, et al. Validated LC-MS/MS method lipoproteins after breast cancer treatment. Front Oncol.
of sphingosine 1-phosphate quantification in human serum 2022;12:919522.
for evaluation of response to radiotherapy in lung cancer. doi: 10.3389/fonc.2022.919522
Thorac Cancer. 2020;11(6):1443-1452.
21. Huang F, Li S, Wang X, et al. Serum lipids concentration
doi: 10.1111/1759-7714.13409
on prognosis of high-grade glioma. Cancer Causes Control.
11. Minghe LV, Shao S, Du Y, Zhuang X, Wang X, Qiao T. Plasma 2023;34(9):801-811.
lipidomics profiling to identify the biomarkers of diagnosis doi: 10.1007/s10552-023-01710-1
and radiotherapy response for advanced non-small-cell lung
cancer patients. J Lipids. 2024;2024:6730504. 22. Wang, CT, Chen MY, Guo X, et al. Association between
pretreatment serum high-density lipoprotein cholesterol
doi: 10.1155/2024/6730504 and treatment outcomes in patients with locoregionally
12. Han D, Dong J, Wang Q, et al. Neoadjuvant radiation target advanced nasopharyngeal carcinoma treated with
volume definition in esophageal squamous cell cancer: A chemoradiotherapy: Findings from a randomised trial. J
multicenter recommendations from Chinese experts. BMC Cancer. 2019;10(16):3618-3623.
Cancer. 2024;24(1):1086.
doi: 10.7150/jca.32621
doi: 10.1186/s12885-024-12825-2 23. Zhang J, Shang S, Wang F, et al. The baseline serum lipid levels
13. Zemanova M, Vecka M, Petruželka L, Staňková B, and outcomes of NSCLC patients receiving immunotherapy
Žák A, Zeman M. Plasma phosphatidylcholines fatty combined or non-combined with radiotherapy: A single
acids in men with squamous cell esophageal cancer: center retrospective study. Int J Radiat Oncol Biol Phys.
Chemoradiotherapy improves abnormal profile. Med Sci 2023;117(2 Suppl):e11.
Monit. 2016;22:4092-4099. doi: 10.1016/j.ijrobp.2023.06.670
doi: 10.12659/MSM.896799
24. Harima Y, Ariga T, Kaneyasu Y, et al. Clinical value of
14. Buskwofie A, David-West G, Clare CA. A review of serum biomarkers, squamous cell carcinoma antigen and
cervical cancer: Incidence and disparities. J Natl Med Assoc. apolipoprotein C-II in follow-up of patients with locally
2020;112:229-32. advanced cervical squamous cell carcinoma treated with
radiation: A multicenter prospective cohort study. PLoS
doi: 10.1016/j.jnma.2020.03.002
One. 2021;16(11):e0259235.
15. Xu X, Ping P, Zhang Z, Zou L. Plasma free fatty acid levels in doi: 10.1371/journal.pone.0259235
cervical cancer: Concurrent chemoradiotherapy improves
abnormal profile. Front Pharmacol. 2024;15:1352101. 25. Guo SP, Chen C, Zeng ZF, et al. Serum apolipoprotein
a-I predicts response of rectal cancer to neoadjuvant
doi: 10.3389/fphar.2024.1352101
chemoradiotherapy. Cancer Manag Res. 2021;13:2623-2631.
16. Ganesan P, Kulik LM. Hepatocellular carcinoma: New doi: 10.2147/CMAR.S302677
developments. Clin Liver Dis. 2023;27(1):85-102.
26. Jung E, Kong SY, Ro YS, Ryu HH, Shin SD. Serum cholesterol
doi: 10.1016/j.cld.2022.08.004
levels and risk of cardiovascular death: A systematic review
17. Sylvia SW, Jang GH, Kurland IJ, Qiu Y, Guha C, Dawson LA. and a dose-response meta-analysis of prospective cohort

Volume 3 Issue 2 (2025) 22 doi: 10.36922/ARNM025070006